W. Kang

Terminal neuroendocrine differentiation of human prostate carcinoma cells in response to increased intracellular cyclic AMP.

Yung‐Jue Bang, Farzaneh Pirnia, Wen‐Ning Fang et al. · Proceedings of the National Academy of Sciences · 1994 · 247 citations

Life Sciences, Cell Biology, Oncology +17

A randomised, double-blind, placebo-controlled multi-centre phase III trial of XELIRI/FOLFIRI plus simvastatin for patients with metastatic colorectal cancer

Seong Hoon Lim, Tae Won Kim, Yuancheng Hong et al. · British Journal of Cancer · 2015 · 89 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Randomized phase III ANGEL study of rivoceranib (apatinib) + best supportive care (BSC) vs placebo + BSC in patients with advanced/metastatic gastric cancer who failed ≥2 prior chemotherapy regimens

Yoon‐Koo Kang, W. Kang, Maria Di Bartolomeo et al. · Annals of Oncology · 2019 · 73 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Somatic VHL alteration and its impact on prognosis in patients with clear cell renal cell carcinoma

Jung Ho Kim, H. Y. Kim, Chul Won Jung et al. · Journal of Clinical Oncology · 2005 · 38 citations

Medicine, Cancer Biology, Oncology +14

Gastric GIST: A single institutional retrospective experience with surgical treatment for primary disease

Ji Yeong An, Min Gew Choi, Jung Hyun Noh et al. · European Journal of Surgical Oncology · 2007 · 35 citations

Medicine, Oncology, Surgery +11